Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SRNE

Sorrento Therapeutics (SRNE)

Sorrento Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SRNE
DateTimeSourceHeadlineSymbolCompany
11/03/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
10/27/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
09/12/20238:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
08/28/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
08/07/20233:15PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SRNESorrento Therapeutics Inc
08/01/20235:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
07/13/20235:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
06/21/20234:25PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
06/20/20234:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
06/15/20238:44AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
06/05/20238:00AMGlobeNewswire Inc.Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the ANASDAQ:SRNESorrento Therapeutics Inc
05/19/20235:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
05/15/20232:18PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SRNESorrento Therapeutics Inc
05/15/202311:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
05/12/20234:29PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
05/09/20235:03AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SRNESorrento Therapeutics Inc
05/03/20235:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
04/20/20234:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
04/20/202311:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
04/12/20237:51AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRNESorrento Therapeutics Inc
04/10/20234:23PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SRNESorrento Therapeutics Inc
04/10/20232:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
03/31/20235:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
03/20/20236:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRNESorrento Therapeutics Inc
03/20/20235:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
03/10/202310:22AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
03/08/20231:20PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
02/22/20238:25AMAllPennyStocks.comBankruptcy Court Approval Causes Premarket Buying PressureNASDAQ:SRNESorrento Therapeutics Inc
02/21/20234:57PMPR Newswire (US)Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 CaseNASDAQ:SRNESorrento Therapeutics Inc
02/21/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SRNE